Clinical Trial Update: Rituximab in New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab in new onset type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2016-08-18